The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Researchers have found preliminary evidence that combining the hallucinogenic compound psilocybin with cognitive behavioral ...

Light therapy is linked to reduced symptoms of depression and improved sleep quality in patients with neuropsychiatric ...

Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced positive topline data from its Phase 2 AMPLIFY ...

Mental health professionals use the DSM to standardize the diagnosis and treatment processes for mental health conditions, including types of depression. The Diagnostic and Statistical Manual of ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Pediatric patients with neurodevelopmental disorders experience a substantially increased risk for co-occurring psychiatric conditions.

The word depressive comes from depress, stemming from the Latin depressare, meaning to “press down.” For example, we can press down on, or depress, a lever. Whenever you press a key or drive and step ...